CDKN2A deletion is associated with immune desertification in diffuse pleural mesothelioma

Abstract Introduction Diffuse Pleural Mesothelioma (DPM) is a rare and incurable cancer. Immune checkpoint inhibitors (ICIs) marked some advances but only for a limited fraction of patients. Improving response prediction to ICIs is currently a clinical need in DPM. Deletion of CDKN2A gene, in chr9p2...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Federica Torricelli, Benedetta Donati, Veronica Manicardi, Mila Gugnoni, Francesca Reggiani, Gloria Manzotti, Pierluigi Di Chiaro, Cristian Ascione, Simonetta Piana, Riccardo Valli, Roberto Piro, Massimiliano Paci, Nicola Facciolongo, Filippo Lococo, Alessia Ciarrocchi
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2025-08-01
Colecção:Journal of Experimental & Clinical Cancer Research
Assuntos:
Diffuse pleural mesothelioma
Tumor immune microenvironment
Genetic alteration
CDKN2A
Immunotherapy
Acesso em linha:https://doi.org/10.1186/s13046-025-03522-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados